pulmonologyadvisor20h
Dupilumab in COPD Linked to Lower Mortality, Better Long-Term Outcomes
Dupilumab in COPD was associated with decreased risk of mortality, emergency visits, exacerbations, and respiratory failure and infections.
pulmonologyadvisor20h
Residual Sleepiness, CPAP Adherence Predict Driving Risk for Patients With OSA
For people with OSA being treated with CPAP therapy, residual sleepiness at the wheel was the strongest predictor of persistent driving risk.
pulmonologyadvisor20h
FDA Extends Review of Tapinarof Cream for Atopic Dermatitis
The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.
pulmonologyadvisor20h
Donidalorsen Under Review for Hereditary Angioedema
The FDA has accepted the NDA for donidalorsen for the prophylactic treatment of hereditary angioedema in patients aged 12 years and older.